Literature DB >> 26950376

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.

A Varma1,2, R M Saliba2, H A Torres3, A Afrough2, C Hosing2, I F Khouri2, Y Nieto2, N D Shah2, S Parmar2, Q Bashir2, S Ahmed2, R B Jones2, P Kebriaei2, A L Olson2, E J Shpall2, A M Alousi2, M H Qazilbash2, R E Champlin2, U Popat2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26950376     DOI： 10.1038/bmt.2016.28

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

1.  The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.

Authors:  A Locasciulli; M Testa; M G Valsecchi; A Bacigalupo; S Solinas; J F Tomas; P Ljungman; A Alberti
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

2.  Causes and risk factors for liver injury following bone marrow transplantation.

Authors:  Osman Ozdoğan; Siret Ratip; Yeşim Al Ahdab; Faysal Dane; Hicham Al Ahdab; Neşe Imeryüz; Nurdan Tözün
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

3.  Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.

Authors:  Parag Mahale; Dimitrios P Kontoyiannis; Roy F Chemaly; Ying Jiang; Jessica P Hwang; Marta Davila; Harrys A Torres
Journal:  J Hepatol       Date:  2012-08-04       Impact factor: 25.083

Review 4.  European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma.

Authors:  B Björkstrand
Journal:  Semin Hematol       Date:  2001-07       Impact factor: 3.851

5.  Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.

Authors:  S I Strasser; D Myerson; C L Spurgeon; K M Sullivan; B Storer; H G Schoch; S Kim; M E Flowers; G B McDonald
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

6.  High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies.

Authors:  Jun Kang; Jeong Hyun Cho; Cheol Won Suh; Dae Ho Lee; Heung Bum Oh; Yong Hak Sohn; Hyun Sook Chi; Chan Jeong Park; Sung Soo Jang; Kyoo Hyung Lee; Je-Hwan Lee; Jung Hee Lee; Sang Wook Lee; Young Hwa Chung; Tae Hyup Kim; Hai-Rim Shin; Jooryung Huh
Journal:  Ann Hematol       Date:  2010-09-07       Impact factor: 3.673

7.  Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.

Authors:  Christian Gisselbrecht; Bertram Glass; Nicolas Mounier; Devinder Singh Gill; David C Linch; Marek Trneny; Andre Bosly; Nicolas Ketterer; Ofer Shpilberg; Hans Hagberg; David Ma; Josette Brière; Craig H Moskowitz; Norbert Schmitz
Journal:  J Clin Oncol       Date:  2010-07-26       Impact factor: 44.544

8.  High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Authors:  J Anthony Child; Gareth J Morgan; Faith E Davies; Roger G Owen; Susan E Bell; Kim Hawkins; Julia Brown; Mark T Drayson; Peter J Selby
Journal:  N Engl J Med       Date:  2003-05-08       Impact factor: 91.245

9.  Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Carlos A Ramos; Rima M Saliba; Leandro de Pádua; Ola Khorshid; Elizabeth J Shpall; Sergio Giralt; Poliana A Patah; Chitra M Hosing; Uday R Popat; Gabriela Rondon; Issa F Khouri; Yago L Nieto; Richard E Champlin; Marcos de Lima
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

10.  Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.

Authors:  Yago Nieto; Uday Popat; Paolo Anderlini; Ben Valdez; Borje Andersson; Ping Liu; Chitra Hosing; Elizabeth J Shpall; Amin Alousi; Partow Kebriaei; Muzaffar Qazilbash; Simrit Parmar; Qaiser Bashir; Nina Shah; Issa Khouri; Gabriela Rondon; Richard Champlin; Roy B Jones
Journal:  Biol Blood Marrow Transplant       Date:  2012-11-02       Impact factor: 5.742
View more
  2 in total

1.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

Review 2.  Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy.

Authors:  Kohtaro Ooka; Joseph K Lim
Journal:  J Clin Transl Hepatol       Date:  2016-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.